Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings yield high or low?
The earnings yield of 6.19% is 24% above its 5-year average of 5.00%, near the high end of its 5-year range (4.10%–6.19%).
37.56% above its 12-month average of 4.50%.
Reported annual fiscal-period values; no daily interpolation.
EARNINGS YIELD
6.19%
EARNINGS YIELD AVG TTM
4.50%
EARNINGS YIELD AVG 3Y
5.07%
EARNINGS YIELD AVG 5Y
5.00%
EARNINGS YIELD AVG 10Y
4.80%
EARNINGS YIELD AVG 15Y
5.00%
EARNINGS YIELD AVG 20Y
5.15%
CURRENT VS TTM AVG
+37.56%
CURRENT VS 3Y AVG
+22.15%
CURRENT VS 5Y AVG
+23.80%
CURRENT VS 10Y AVG
+29.08%
CURRENT VS 15Y AVG
+23.87%
CURRENT VS 20Y AVG
+20.28%
SECTOR MEDIAN · HEALTHCARE
3.60%
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
+71.94%
vs the sector median at left
Market Cap
$358.76B
Earnings Yield
3.94%
TTM Avg
5.01%
3Y Avg
4.54%
5Y Avg
4.27%
Market Cap
$234.38B
Earnings Yield
2.95%
TTM Avg
3.36%
3Y Avg
3.17%
5Y Avg
3.24%
Market Cap
$193.04B
Earnings Yield
2.73%
TTM Avg
4.97%
3Y Avg
4.08%
5Y Avg
3.90%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Roche Holding AG (RHHBY) | $359.46B | 6.19% | 4.50% | 5.07% | 5.00% |
| UnitedHealth Group Incorporated (UNH)vs › | $358.76B | 3.94% | 5.01% | 4.54% | 4.27% |
| Merck & Co., Inc. (MRK)vs › | $369.34B | 0.82% | 5.65% | 4.47% | 4.71% |
| AbbVie Inc. (ABBV)vs › | $455.87B | 1.35% | 0.90% | 1.51% | 2.53% |
| AstraZeneca PLC (AZN)vs › | $255.15B | 4.00% | 3.45% | 3.01% | 2.49% |
| Amgen Inc. (AMGN)vs › | $235.85B | 3.65% | 4.02% | 3.66% | 4.15% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $234.38B | 2.95% | 3.36% | 3.17% | 3.24% |
| Novo Nordisk A/S (NVO)vs › | $205.42B | 8.60% | 7.95% | 4.77% | 3.99% |
| Abbott Laboratories (ABT)vs › | $193.04B | 2.73% | 4.97% | 4.08% | 3.90% |
| Gilead Sciences, Inc. (GILD)vs › | $184.82B | N/A | 4.94% | 3.68% | 4.54% |
Earnings Yield
6.19%
EPS ÷ Price
P/E Ratio
16.1
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2025-12-31 | 4.90% |
| 2024-12-31 | 4.10% |
| 2023-12-31 | 5.91% |
| 2022-12-31 | 5.36% |
| 2021-12-31 | 4.35% |
| 2020-12-31 | 5.38% |
| 2019-12-31 | 5.01% |
| 2018-12-31 | 5.03% |
| 2017-12-31 | 4.09% |
| 2016-12-31 | 4.84% |
| 2015-12-31 | 3.78% |
| 2014-12-31 | 4.07% |
| 2013-12-31 | 5.17% |
| 2012-12-31 | 6.08% |
| 2011-12-31 | 6.89% |
| 2010-12-31 | 7.40% |
| 2009-12-31 | 5.19% |
| 2008-12-31 | 6.36% |
| 2007-12-31 | 5.87% |
| 2006-12-31 | 4.25% |
| 2005-12-31 | 4.04% |
| 2004-12-31 | 5.95% |
| 2003-12-31 | 2.92% |
| 2002-12-31 | -8.29% |
| 2001-12-31 | 6.38% |
| 2000-12-31 | 10.61% |
| 1999-12-31 | 6.96% |
| 1998-12-31 | 3.45% |
